Colorectal cancer screening for average-risk North Americans: an economic evaluation.
about
Population-based programs for increasing colorectal cancer screening in the United StatesCMOST: an open-source framework for the microsimulation of colorectal cancer screening strategiesAn empirical comparison of methods for analyzing correlated data from a discrete choice survey to elicit patient preference for colorectal cancer screening.Virtual gastrointestinal colonoscopy in combination with large bowel endoscopy: clinical applicationTumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateNon-medical costs of colonoscopyRecommendations on screening for colorectal cancer in primary care.Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screeningGenetic pathways, prevention, and treatment of sporadic colorectal cancerUse of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for CanadaGuaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening ProgrammeChoosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.Progress and challenges in colorectal cancer screening.The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective StudyA pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009.The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test.Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screeningUse of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study.Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes.Association Between Exposure to Environmental Tobacco Smoke at the Workplace and Risk for Developing a Colorectal Adenoma: A Cross-Sectional Study.Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model.Validity of APCS score as a risk prediction score for advanced colorectal neoplasia in Chinese asymptomatic subjects: A prospective colonoscopy study.Review of economic evidence in the prevention and early detection of colorectal cancer.Strategies to improve repeat fecal occult blood testing cancer screening.Comparison of One versus Two Fecal Immunochemical Tests in the Detection of Colorectal Neoplasia in a Population-Based Colorectal Cancer Screening ProgramColorectal cancer screening: Opportunities to improve uptake, outcomes, and disparities.Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study.Screening for colorectal cancer: what fits best?Noninvasive screening tests for colorectal cancer.Programmatic screening for colorectal cancer: the COLONPREV study.Cost analysis of colorectal cancer screening with CT colonography in Italy.Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool.Diterpenoid C of Radix Curcumae: an inhibitor of proliferation and inducer of apoptosis in human colon adenocarcinoma cells acting via inhibiting MAPK signaling pathway.A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
P2860
Q26786602-7A7EA2F6-4611-4300-A5CB-8BFDB9EA5684Q33768335-0F749CD1-F16E-4BFD-AB34-2331460C66FEQ34164094-333052DC-C282-4817-8A93-BF304B92FCB6Q34326632-E9724AA3-D861-477E-94FD-6BA003A5EB13Q34441837-258BA2ED-E1A9-43A0-9438-FE6171378050Q34466635-4AE9E952-B6C1-4F91-9028-3164DCA1C198Q34515159-1FA3C84A-70BA-48F2-9ABE-2BCF1D26D9FEQ34576842-1A7B71B2-F3CF-450C-9650-853C5658FC58Q34832690-267C2109-0BFB-4903-8CD5-F690CB672A48Q35148262-62A381A5-7EF0-43C3-B98D-405482288456Q35445134-C61A0E43-BEA2-4224-9F8F-71BD090D9270Q35678074-ECF5E9E0-F9E8-4D94-9E51-04158723A5F8Q35780915-1232CC09-C1C2-4EFA-A8F1-CD26BD06352BQ35809264-95E2FF4B-1F0F-4616-BC9A-3F57A1E7E0DBQ35884919-7C9A576B-89AD-46E1-A112-99E432CFCE21Q36026152-1231F3C1-C491-48BD-99E0-6E9353D8634BQ36033510-CF9ED547-FEDB-4ACD-9018-1525DACE15A3Q36047981-7BCAA460-FD3A-46F2-9D3C-EF1C63277E19Q36083030-870F985C-D02E-47C5-B6B1-632A429FE68FQ36095716-36D0B60A-9A2A-4854-934F-33A108B94098Q36309075-9862AB49-4FC8-4CBE-BE19-77763F3C3D23Q36405811-24019AE7-AA61-4A05-A8A7-C4E2CD2E5264Q36759309-F816BEAA-80E7-426E-953B-1A84F89E93E0Q36896758-CD747F9C-4D66-4959-B7E7-4C4EE4DD918FQ37028861-650A3718-4BC0-4FB9-85C5-3A5533B30BD2Q37079386-8E65B09B-FBB1-4DD3-9A53-4653EDAEFAA2Q37225891-4FA62122-969C-4E90-B260-8EA7F4495B0EQ37354835-618C61E7-FA9D-4AD7-B808-C21C4A32F0DBQ37356637-7799A1EF-BF73-456D-91C8-76F39E0C16F5Q37489933-3C196A01-CA54-4EE0-B581-760594ABC4A5Q37503972-D405B6B9-DE20-4682-8FC8-73A29E2A6988Q37507961-1617766F-1DA4-4EE7-8247-7F74EF277D19Q37571510-1A70D74C-A8F3-4DED-B3F1-29BE021E8EE2Q38014494-A3626A9A-65BE-4BC6-B057-AEF5D9D73BFAQ38064739-522C7CC0-A65B-4316-9DF3-1BE9F92BF910Q38285934-1E647C55-0630-4A69-B56F-1BBD5A9A81BEQ38691876-9A041883-CEFC-4550-B88B-D2C362979EB7Q38825618-E565EC70-BE37-4C2D-84B1-801F7E3A3FBAQ39013941-D0E73557-1C0C-4FC8-B40D-54CCDAF83713Q39454414-AA5C5515-4080-4240-B612-72876E9E45D6
P2860
Colorectal cancer screening for average-risk North Americans: an economic evaluation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Colorectal cancer screening for average-risk North Americans: an economic evaluation.
@ast
Colorectal cancer screening for average-risk North Americans: an economic evaluation.
@en
type
label
Colorectal cancer screening for average-risk North Americans: an economic evaluation.
@ast
Colorectal cancer screening for average-risk North Americans: an economic evaluation.
@en
prefLabel
Colorectal cancer screening for average-risk North Americans: an economic evaluation.
@ast
Colorectal cancer screening for average-risk North Americans: an economic evaluation.
@en
P2093
P2860
P1433
P1476
Colorectal cancer screening for average-risk North Americans: an economic evaluation
@en
P2093
Braden J Manns
Scot Dowden
Steven J Heitman
P2860
P304
P356
10.1371/JOURNAL.PMED.1000370
P407
P577
2010-11-23T00:00:00Z